ICU MEDICAL INC/DE

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $63.1m $68.6m $28.8m $101.0m $86.9m $103.1m ($74.3m) ($29.7m) ($117.7m) $732k
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $85.2m
Depreciation, Depletion and Amortization $19.1m $66.6m $74.7m $76.9m $85.6m $89.7m $235.2m $228.8m $219.5m $200.7m
Depreciation $16.3m $51.6m $58.1m $59.3m $62.4m $65.9m $95.8m $96.7m $85.2m $69.3m
Amortization of Debt Issuance Costs $0 $48k $288k $288k $288k $240k $7.0m $6.8m $6.8m $6.2m
Amortization of Debt Issuance Costs and Discounts $0 $48k $288k $288k $288k $240k $7.0m $6.8m $6.8m $8.9m
Amortization of Intangible Assets $2.8m $15.0m $16.6m $17.7m $23.2m $23.8m $139.4m $132.1m $134.3m $131.4m
Deferred Income Tax Expense (Benefit) ($2.5m) ($25.6m) ($17.9m) ($3.7m) ($5.1m) ($11.3m) ($61.0m) ($71.5m) $5.7m ($13.8m)
Share-based Payment Arrangement, Noncash Expense $15.2m $19.4m $24.2m $21.9m $24.0m $27.3m $36.0m $40.6m $46.9m $55.8m
Payment, Tax Withholding, Share-based Payment Arrangement $1.9m $4.1m $6.3m $18.6m $12.9m $8.3m $10.9m $9.4m $12.0m $8.8m
Goodwill, Impairment Loss $0
Impairment of Intangible Assets, Finite-lived $5.0m $0 $0
Gain (Loss) on Disposition of Assets $0 $0 $0 $0 $374k $0 $0 ($44.8m)
Gain (Loss) on Disposition of Business $0 $0 $374k $0 $0 $44.8m
Gain (Loss) on Disposition of Other Assets $0 $0 ($2.6m) ($153k) ($1.6m) ($4.4m)
Gain (Loss) on Disposition of Property Plant Equipment ($59k) ($3.8m) ($8.9m) ($12.9m) $1.8m ($1.7m) ($2.0m) ($2.1m) ($2.5m) ($5.9m)
Gain (Loss) on Extinguishment of Debt $0 $0 ($2.5m)
Income (Loss) from Equity Method Investments $0 $0 ($1.2m)
Income Tax Expense (Benefit) $22.1m ($17.4m) ($6.4m) $13.7m $10.6m $20.1m ($40.1m) ($48.6m) $51.7m $2.4m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($744k) $54.5m $76.7m $23.7m ($78.0m) ($13.8m) $19.2m ($48.6m) $46.8m ($8.9m)
Increase (Decrease) in Inventories $5.5m ($181.7m) $21.8m $25.0m ($19.2m) ($20.8m) $201.1m $6.1m ($16.8m) $26.3m
Increase (Decrease) in Accounts Payable ($463k) $46.6m $23.3m ($2.7m) ($46.4m) $2.3m $37.5m ($68.3m) $12.5m $7.0m
Proceeds from Stock Options Exercised $17.3m $32.0m $14.3m $7.7m $13.2m $9.4m $8.8m $4.0m $10.9m $6.1m
Foreign Currency Transaction Gain (Loss), Realized $300k ($1.8m) ($7.9m) $700k ($7.2m) ($1.0m) ($5.8m) ($5.9m) ($9.8m) $3.8m
Goodwill $5.6m $12.4m $11.2m $31.2m $33.0m $43.4m $1.4b $1.5b $1.4b $1.5b
Nonoperating Income (Expense) $767k ($2.5m) $1.5m $7.9m $1.1m $799k ($5.1m) ($5.9m) ($13.2m) ($232k)
Operating Expenses $118.5m $441.2m $548.4m $364.5m $363.3m $368.2m $740.7m $717.0m $781.8m $779.2m
Restructuring Costs $774k $18.8m $4.5m $8.4m $7.9m $140k $9.7m $6.7m $19.6m $30.0m
Derivative, Gain (Loss) on Derivative, Net $885k $743k $916k $790k $3.4m $14.4m
Other Operating Income (Expense), Net ($5.1m) ($5.9m) ($13.2m) ($232k)
Net Cash Provided by (Used in) Operating Activities $89.9m $154.4m $160.2m $101.9m $222.8m $267.5m ($62.1m) $166.2m $204.0m $179.8m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $23.4m $74.5m $92.7m $97.3m $92.0m $68.5m $90.3m $83.9m $79.4m $88.0m
Payments to Acquire Businesses, Net of Cash Acquired $2.6m $162.4m $1.3m $76.1m $0 $14.5m $1.8b $0 $0
Net Cash Provided by (Used in) Investing Activities $16.3m ($266.9m) ($103.4m) ($166.9m) ($98.1m) ($90.7m) ($1.9b) ($87.9m) ($89.0m) $122.2m
Cash flows from financing activities:
Repayments of Long-term Debt $75.0m $0 $0 $150.0m $0 $22.4m $29.7m $51.0m $302.8m
Payments for Repurchase of Common Stock $17.2m $4.1m $6.3m $18.6m $12.9m $8.3m $10.9m $9.3m $12.0m $8.8m
Net Cash Provided by (Used in) Financing Activities $2.5m ($44.3m) $8.0m ($10.9m) ($40k) ($16.9m) $1.6b ($36.0m) ($55.8m) ($311.5m)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $54.7m ($76.1m) $127.4m $156.7m ($9.5m) $3.2m ($4.9m) $8.8m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $54.7m $127.4m $156.7m ($344.0m) $45.4m $54.3m ($603k)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $54.7m ($76.1m) $127.4m $156.7m $208.8m $254.2m $308.6m $308.0m
Cash, Cash Equivalents, and Short-term Investments $445.1m $300.1m $382.1m $292.6m $410.8m $567.2m $213.0m $254.7m $308.6m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $118k $2.0m $709k $549k $1.8m $858k $63.7m $95.9m $99.7m $83.7m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.